Approximately 1 – 5 % of the world‘s population suffers from Eustachian Tube Dysfunction (ETD).1, 2 Balloon dilation of the Eustachian tube has been established as a minimally invasive causal therapy for obstructive ETD. Recognized as a safe and effective procedure, BET has been widely studied. Multiple studies have demonstrated that the TubaVent® Balloon Catheter can successfully restore normal ear function, leading to high patient TubaVent® short satisfaction.3, 4 Since its launch in 2010 in Europe, TubaVent® has been used in over 125,000 cases worldwide, solidifying its position as a trusted solution for ETD treatment.
As a pioneer and market leader in ETD, SPIGGLE & THEIS is committed to continuous innovation – together with leading ENT experts – in order to adapt products specifically to clinical requirements and market needs. Our latest development - the TubaInsert ONE®
TubaVent® short – the latest balloon dilation catheter from SPIGGLE & THEIS – enables minimally invasive tube dilation in combination with the TubaInsert® or TubaInsert ONE® insertion device.
The multi-use combination instrument enables Eustachian Tube Dysfunctions to be easily treated. The entry angles which are available make it possible to fulfill all anatomical conditions.
TubaVent® und TubaVent® wide in combination with the insertion instrument, enable minimally invasive Eustachian tube dilation.
Specially developed for the treatment of obstructive Eustachian Tube Dysfunction
The catheter tip allows for easy advancement of the catheter while providing optimal protection for the mucous membrane cleaning system